Dr. Jacquelyn Sara Carr, MD

Dr. Carr practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Carr's NPI, 1104117910, was assigned on April 27, 2011. Dr. Carr graduated from Emory University School of Medicine in 2011. Dr. Carr holds Pennsylvania license MD471804.

Dr. Carr's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Carr's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Carr is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Carr to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carr practices, 7 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Carr's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Carr is licensed in Pennsylvania.

CMS data shows 331 Medicare services from Dr. Carr across 7 procedure codes in 2024, for 222 Medicare patients. Medicare paid $39,148 for them.

CMS counts 222 Medicare patients who saw Dr. Carr in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carr's median patient age at 71, with 46% women.

In 2024, Dr. Carr wrote 98 Medicare Part D claims for 65 patients. 88% of them were for generic drugs. CMS names the drug for 27 of them, across 1 drug with 11 or more claims each, at $44 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Carr for performance year 2024, reported through an alternative payment model (APM). Dr. Carr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carr as offering telehealth. CMS counts 27 procedures of melanoma (skin cancer) excision by Dr. Carr, more than 79% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Carr, published from 2012 to 2024. 2016 was the busiest year, with 4. The most frequent topics are Appendiceal Neoplasms, Heart Injuries and Pancreatic Neoplasms. Dr. Carr has published most often in Ann Surg Oncol. Dr. Carr's most frequent co-authors are Umut Sarpel, MD, Deepa Ramakumar Magge, MD and Daniel Erik Abbott, MD.

CMS Open Payments shows 14 general payments to Dr. Carr from 4 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 72% of the total. Intuitive Surgical, Inc. paid the most, $1,958.

Dr. Carr graduated from Emory University School of Medicine in 2011.